Answers are grounded in this paper and cite their sources.
The aim of this review is to report on the value of 11C-choline PET imaging as a diagnostic procedure for metastasis-directed therapies. Furthermore, the role of 11C-choline PET/CT as a diagnostic tool for monitoring castration-resistant prostate cancer patients treated with systematic therapy is assessed. Finally, the role of 11C-choline PET/CT in the prediction of survival in both castration-resistant prostate cancer patients and hormone-naïve patients is investigated.
No takes yet. Share an insight, caveat, or question.
Ceci et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: